Trial Outcomes & Findings for An Innovative Conversational Agent (Quitbot) for Smoking Cessation (NCT NCT04308759)

NCT ID: NCT04308759

Last Updated: 2026-05-22

Results Overview

The primary endpoint is 30-day point prevalence abstinence for cigarette smoking at 12 months post-randomization. At 12 months, smoking abstinence is assessed by asking participants: "When was the last time you smoked, or even tried, a cigarette?" Response choices are "Earlier today", "24 hours ago", "2-7 days ago", "8-30 days ago", and "Over 30 days ago". Participants reporting no cigarette consumption in the past 30 days are considered abstinent for the 30-day outcome. Missing outcome data are handled using standard intent-to-treat analysis, with all missing data coded as smoking.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

1647 participants

Primary outcome timeframe

At 12 months after randomization

Results posted on

2026-05-22

Participant Flow

Adults who smoke were recruited nationally from 07/24/2022 to 01/25/2024 via Facebook ads, search engine results, and referral from friend and family.

Participant milestones

Participant milestones
Measure
Group II (SmokefreeTXT Control)
Participants participate in the SmokefreeTXT program for 42 days to support quitting smoking. SmokefreeTXT is a standard of care smoking cessation text messaging program from the NCI.
Group I (QuitBot Experimental)
Participants participate in the QuitBot program for 42 days to support quitting smoking. QuitBot is a novel chatbot smartphone application for smoking cessation.
3-Month Follow-up Survey
STARTED
826
821
3-Month Follow-up Survey
COMPLETED
758
734
3-Month Follow-up Survey
NOT COMPLETED
68
87
6-Month Follow-up Survey
STARTED
826
821
6-Month Follow-up Survey
COMPLETED
733
720
6-Month Follow-up Survey
NOT COMPLETED
93
101
12-Month Follow-up Survey
STARTED
826
821
12-Month Follow-up Survey
COMPLETED
723
704
12-Month Follow-up Survey
NOT COMPLETED
103
117

Reasons for withdrawal

Reasons for withdrawal
Measure
Group II (SmokefreeTXT Control)
Participants participate in the SmokefreeTXT program for 42 days to support quitting smoking. SmokefreeTXT is a standard of care smoking cessation text messaging program from the NCI.
Group I (QuitBot Experimental)
Participants participate in the QuitBot program for 42 days to support quitting smoking. QuitBot is a novel chatbot smartphone application for smoking cessation.
3-Month Follow-up Survey
Lost to Follow-up
68
87
6-Month Follow-up Survey
Lost to Follow-up
93
101
12-Month Follow-up Survey
Lost to Follow-up
103
117

Baseline Characteristics

An Innovative Conversational Agent (Quitbot) for Smoking Cessation

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Group II (SmokefreeTXT Control)
n=826 Participants
Participants participate in the SmokefreeTXT program for 42 days to support quitting smoking. SmokefreeTXT is a standard of care smoking cessation text messaging program from the NCI.
Group I (QuitBot Experimental)
n=821 Participants
Participants participate in the QuitBot program for 42 days to support quitting smoking. QuitBot is a novel chatbot smartphone application for smoking cessation.
Total
n=1647 Participants
Total of all reporting groups
Race (NIH/OMB)
Asian
2 Participants
n=2 Participants
4 Participants
n=4 Participants
6 Participants
n=6 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
2 Participants
n=2 Participants
0 Participants
n=4 Participants
2 Participants
n=6 Participants
Race (NIH/OMB)
Black or African American
108 Participants
n=2 Participants
110 Participants
n=4 Participants
218 Participants
n=6 Participants
Age, Continuous
42.4 Years
STANDARD_DEVIATION 9.8 • n=2 Participants
42.5 Years
STANDARD_DEVIATION 10.0 • n=4 Participants
42.4 Years
STANDARD_DEVIATION 9.8 • n=6 Participants
Sex/Gender, Customized
Sex: Female, Male · Female
504 Participants
n=2 Participants
501 Participants
n=4 Participants
1005 Participants
n=6 Participants
Sex/Gender, Customized
Sex: Female, Male · Male
312 Participants
n=2 Participants
314 Participants
n=4 Participants
626 Participants
n=6 Participants
Sex/Gender, Customized
Sex: Female, Male · Unknown
10 Participants
n=2 Participants
6 Participants
n=4 Participants
16 Participants
n=6 Participants
Race (NIH/OMB)
American Indian or Alaska Native
13 Participants
n=2 Participants
14 Participants
n=4 Participants
27 Participants
n=6 Participants
Race (NIH/OMB)
White
638 Participants
n=2 Participants
641 Participants
n=4 Participants
1279 Participants
n=6 Participants
Race (NIH/OMB)
More than one race
49 Participants
n=2 Participants
46 Participants
n=4 Participants
95 Participants
n=6 Participants
Race (NIH/OMB)
Unknown or Not Reported
14 Participants
n=2 Participants
6 Participants
n=4 Participants
20 Participants
n=6 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
82 Participants
n=2 Participants
46 Participants
n=4 Participants
128 Participants
n=6 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
744 Participants
n=2 Participants
775 Participants
n=4 Participants
1519 Participants
n=6 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=2 Participants
0 Participants
n=4 Participants
0 Participants
n=6 Participants
Education Level
High school or less education
330 Participants
n=2 Participants
291 Participants
n=4 Participants
621 Participants
n=6 Participants
Education Level
Some college or more education
496 Participants
n=2 Participants
530 Participants
n=4 Participants
1026 Participants
n=6 Participants
CESD-20 Depression Screen
CESD-20 score greater than or equal to 16
630 Participants
n=2 Participants
639 Participants
n=4 Participants
1269 Participants
n=6 Participants
CESD-20 Depression Screen
CESD-20 score less than 16
196 Participants
n=2 Participants
182 Participants
n=4 Participants
378 Participants
n=6 Participants
Smoking Level
10 or fewer cigarettes per day
311 Participants
n=2 Participants
326 Participants
n=4 Participants
637 Participants
n=6 Participants
Smoking Level
11-20 cigarettes per day
413 Participants
n=2 Participants
392 Participants
n=4 Participants
805 Participants
n=6 Participants
Smoking Level
21 or more cigarettes per day
102 Participants
n=2 Participants
103 Participants
n=4 Participants
205 Participants
n=6 Participants

PRIMARY outcome

Timeframe: At 12 months after randomization

The primary endpoint is 30-day point prevalence abstinence for cigarette smoking at 12 months post-randomization. At 12 months, smoking abstinence is assessed by asking participants: "When was the last time you smoked, or even tried, a cigarette?" Response choices are "Earlier today", "24 hours ago", "2-7 days ago", "8-30 days ago", and "Over 30 days ago". Participants reporting no cigarette consumption in the past 30 days are considered abstinent for the 30-day outcome. Missing outcome data are handled using standard intent-to-treat analysis, with all missing data coded as smoking.

Outcome measures

Outcome measures
Measure
Group II (SmokefreeTXT Control)
n=826 Participants
Participants participate in the SmokefreeTXT program for 42 days to support quitting smoking. SmokefreeTXT is a standard of care smoking cessation text messaging program from the NCI.
Group I (QuitBot Experimental)
n=821 Participants
Participants participate in the QuitBot program for 42 days to support quitting smoking. QuitBot is a novel chatbot smartphone application for smoking cessation.
Number of Participants With 30-day Cigarette Smoking Cessation
191 Participants
Interval 20.3 to 26.2
186 Participants
Interval 19.9 to 25.7

SECONDARY outcome

Timeframe: At 6 months after randomization

The primary endpoint is 30-day point prevalence abstinence for cigarette smoking at 6 months post-randomization. At 6 months, smoking abstinence is assessed by asking participants: "When was the last time you smoked, or even tried, a cigarette?" Response choices are "Earlier today", "24 hours ago", "2-7 days ago", "8-30 days ago", and "Over 30 days ago". Participants reporting no cigarette consumption in the past 30 days are considered abstinent for the 30-day outcome. Missing outcome data are handled using standard intent-to-treat analysis, with all missing data coded as smoking.

Outcome measures

Outcome measures
Measure
Group II (SmokefreeTXT Control)
n=826 Participants
Participants participate in the SmokefreeTXT program for 42 days to support quitting smoking. SmokefreeTXT is a standard of care smoking cessation text messaging program from the NCI.
Group I (QuitBot Experimental)
n=821 Participants
Participants participate in the QuitBot program for 42 days to support quitting smoking. QuitBot is a novel chatbot smartphone application for smoking cessation.
Number of Participants With 30-day Cigarette Smoking Cessation
159 Participants
153 Participants

Adverse Events

Group I (QuitBot Experimental)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Group II (SmokefreeTXT Control)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Jonathan Bricker

Fred Hutchinson Cancer Center

Phone: 206-667-5074

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place